Use of Low Doses of Interleukin-2 in Autism Spectrum Disorders
Clinical trial NCT07589842 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07589842
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-10-01
- Primary completion
- 2028-11-30
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.